Trutakna (atacicept-vymj), a first-in-class dual BAFF and APRIL inhibitor, secured FDA accelerated approval to reduce proteinuria in adults with primary IgA nephropathy, supported by data ...
There was a substantial increase in recent years in the use of a form of the primary medication to treat opioid use disorder, ...
Federal officials may remove warnings on testosterone therapy drugs about heart and prostate risks, which could expand access ...
For millions of people taking weight loss drugs, the next breakthrough may not be more weight loss. It may be fewer injections. Subscribe to read this story ad-free Get unlimited access to ad-free ...
The controversy over vibe coding reached a new high this week after a developer added hidden instructions to his open source Java testing app to sabotage projects performed by AI coding agents. The ...
You almost certainly know them: Someone who had to retire from soccer because of a hip problem. A grandmother who can't lift her arm to comb her hair because of shoulder pain. A coworker who had a ...
Osteoarthritis affects around 600 million people globally. It causes pain, stiffness and reduced joint function – most commonly in the knees, hands and hips. There’s currently no cure for ...
Knee osteoarthritis is a complex disease that affects the whole joint, including bone, cartilage, ligaments and muscles. Osteoarthritis is a common cause of pain and movement difficulty, affecting 8.3 ...
Digital solution will be designed to help guide users through injection process Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable ...
Los Angeles Lakers star Luka Doncic seeks to do whatever necessary to speed up his injury rehab. Doncic, 27, has reportedly jetted off to Spain in hopes of pursuing specialized treatment for a Grade 2 ...
About a decade ago, a group of competitive CrossFitters in Charleston, South Carolina, went looking for ways to improve their athletic performance without taking steroids. At the time, members of the ...